All Comments by

  1. Timothy Clark on Endowed Lectureship to Honor the Late Mark Smith
  2. Glyn Wainwright on Is Alzheimer's a Type 3 Diabetes?
  3. Glyn Wainwright on Cholesterol and Alzheimer's—Charging Fast But Still at a Distance from Solid Answers
  4. Michael Schlossmacher on Herpes Simplex and Alzheimer’s—Time to Think Again?
  5. Takaomi Saido on Combinatorial Tau pseudophosphorylation: markedly different regulatory effects on microtubule assembly and dynamic instability than the sum of the individual parts.
  6. Takaomi Saido on Two distinct amyloid beta-protein (Abeta) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses.
  7. Bhaskar Das on Design and synthesis of potential retinoid based PET imaging agents to study Alzheimer's disease biology.
  8. Chris Carter on Herpes Simplex and Alzheimer’s—Time to Think Again?
  9. M. Flint Beal on Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
  10. Russell Swerdlow on Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
  11. Barry Boland on Sphingolipid storage affects autophagic metabolism of the amyloid precursor protein and promotes Abeta generation.
  12. Glyn Wainwright on The Role of Insulin Resistance in Brain Aging and Dementia
  13. Robert Moir on Crystal structure of the amyloid-β p3 fragment provides a model for oligomer formation in Alzheimer's disease.
  14. Helen Cunningham on Miami: Is Human Amyloid Imaging Ready for Clinical Trials?
  15. Jose Joaquin Merino on Genetics of FTD: New Gene, PGRN Variety, and a Bit of FUS